VibroSense Dynamics AB (publicly traded) develops and markets medical devices for diagnosis of peripheral neuropathy (nerve damage in hands and feet) to diabetes clinics, health and occupational health services, hospitals, and researchers. The company was founded in 2005 and has its headquarters in Malmö, Sweden.
Follow Vibrosense on Instagram:
Listed on AktieTorget since May 2015, VibroSense Dynamics AB has a portfolio that includes a CE-marked medical device for diagnosing impaired sensitivity on human hands. The device is used clinically in all major centers for Occupational and Environmental Medicine in Sweden and Norway. The company is now developing a new device to diagnose impaired sensitivity in the feet of people with diabetes, a population estimated at over 380 million worldwide.